Filing Details

Accession Number:
0001290929-23-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-30 12:01:43
Reporting Period:
2023-01-27
Accepted Time:
2023-01-30 12:01:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
316253 Enzo Biochem Inc ENZ Services-Medical Laboratories (8071) 132866202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419248 G. James Wolf 105, Flyway Drive
Kiawah Island SC 29455
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2023-01-27 11,800 $1.40 4,090,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 418,500 Indirect See Footnote
Footnotes
  1. The 418,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse, 110,000 shares owned directly by the Reporting Person's sibling and 170,500 shares owned directly by adult children of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any.